0x7dc3de747dc3…7dc3de77

ConfirmedFunding & Business453 vB76 sat/vB2 min decode

Evernorth Reports $341.89 Million XRP Carrying Value After $271 Million Impairment

Evernorth's Nov. 13 Form 10-Q shows 346.3 million XRP carried at $341.89 million after $271.04 million in impairments, ahead of its Oct. 9 business combination.

Evernorth Puts Sept. 30 XRP Holdings at $342 Million After Impairment
WitnessEvernorth Puts Sept. 30 XRP Holdings at $342 Million After ImpairmentFirmbee / pixabay

Outputs

  1. Evernorth filed an unaudited Form 10-Q on Nov. 13 showing XRP carried at $341.89 million against $846.58 million historical cost at Sept. 30.

  2. Accumulated XRP impairment totaled $271.04 million through nine months, including $6.89 million in Q3.

  3. Holdings stood at 346,284,972 XRP at Sept. 30; about 473 million XRP after the Oct. 9 business combination.

  4. Shares began trading on Nasdaq under XRPN on Oct. 12.

  5. Nine-month net loss was $32.87 million; Q3 net income was $155.26 million.

Evernorth Holdings Inc. carried its XRP treasury at $341.89 million as of Sept. 30, against $846.58 million in historical cost, according to an unaudited Form 10-Q filed Nov. 13. The gap reflects $271.04 million in accumulated impairment charges, including $6.89 million recorded in the third quarter alone.

The Sept. 30 snapshot covers the period before Evernorth completed its business combination on Oct. 9. At that date, the company held 346,284,972 XRP. After the transaction closed, its holdings rose to approximately 473 million XRP, and its shares began trading on Nasdaq under the ticker XRPN on Oct. 12. The 10-Q figures therefore describe the pre-combination treasury, not the larger position the company holds today.

How the impairment math works

The first half of the year produced $264.1 million in XRP impairments. The third-quarter charge of $6.89 million brought the nine-month total to $271.04 million. In practical terms, the company has written down roughly 32 cents of every dollar of original cost — a reduction that becomes permanent under its accounting policy.

Evernorth treats XRP as an indefinite-lived intangible asset, measured at cost less accumulated impairment. The impairment test for each lot uses the lowest observable intraday price on Coinbase since acquisition. Once a write-down occurs, the reduced value becomes the new cost basis, and it is never marked upward if XRP's price later recovers. The consequence: the $341.89 million carrying value reflects the token's impairment history, not a live market quote.

What does this change for reported earnings?

The filing shows two forces pulling in opposite directions. For the nine months, Evernorth recorded a net loss of $32.87 million, alongside a $240.31 million gain from changes in the fair value of refundable investor advances. The third quarter alone produced $155.26 million in net income, driven by a $162.83 million gain on those same advances. Remeasurement of investor advances, not XRP price moves, dominated the reported earnings picture.

On a cash basis, the picture is narrower. Net cash used in operating activities came to $1.72 million for the nine months. The cash-flow reconciliation lists impairment and advance remeasurement among adjustments to net loss — confirming that the $271.04 million impairment was an accounting write-down, not a comparable cash outflow.

For practitioners, the filing illustrates the structural quirk of intangible-asset accounting for token treasuries under U.S. GAAP: downside is locked in through impairment, upside only surfaces on disposal. As Nasdaq-listed XRPN begins reporting as a public company, each quarterly filing will test whether the post-close treasury of roughly 473 million XRP resets that asymmetry or compounds it.

via tokenpost.com (Source)

More from Nathan Brooks

Nathan Brooks

Show full bio

Market editor covering money, funding and market shifts around crypto and web3 industry at Mempool Brief.

1,512 articles